Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to compare treatment with an endograft prothesis versus antihypertensive treatment in patients with a dissection of the thoracic aorta.


Clinical Trial Description

Patients older than 18 years with type B aortic dissection as diagnosed by computed tomography or magnetic resonance angiography are randomized to either a thoracic aortic endoprosthesis and antihypertensive treatment, called "stent grafting," or a tailored antihypertensive treatment, called "medical treatment."

Only patients in a clinically stable condition and without spontaneous thrombosis of the false lumen after 14 days of the index dissection are considered eligible for study inclusion.

Primary outcome measure is all-cause mortality. Secondary outcome variables include conversion to stent and/or surgery, induced thrombosis of the false lumen, cardiovascular morbidity, aortic expansion (>5 mm/y of maximum diameter including true and false lumina), quality of life, and length of intensive care unit and hospital stay. The study design calls for 136 patients to be randomized and monitored for 24 months. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00525356
Study type Interventional
Source Medtronic Cardiovascular
Contact
Status Completed
Phase Phase 3
Start date February 2002
Completion date September 2007

See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Completed NCT03665558 - Effect of Pacing on Aortic dP/dt Values N/A
Recruiting NCT04149600 - Identification of Genetic Causes of Calcific Aortic Valve Disease
Completed NCT02876263 - Noninvasive Neuromonitoring of Surgery of the Thoracic Aorta N/A
Recruiting NCT03948555 - Magnetic Resonance Imaging (MRI) for Aortic Dissection to Visualise Inflammation
Completed NCT02266342 - GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry
Recruiting NCT05972018 - Liposomal Bupivacaine/Bupivacaine in RS Blocks vs. Ropivacaine in RS Blocks And Catheters Phase 4
Completed NCT03727542 - Influence of Short AV Delay Permanent Pacing on Matrix Metalloproteinase Levels N/A
Not yet recruiting NCT06199401 - Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery N/A
Recruiting NCT06358248 - Standardized Physician-modified Fenestrated Endograft Registry
Recruiting NCT05777681 - Management of Aorto-iliac Infection With BioIntegral Surgical No-React® Bovine Pericardial Xenografts
Recruiting NCT04995640 - CILCA Arch Registry: Management and Outcomes of Open and Endovascular Repair
Recruiting NCT05777460 - Mid- and Long-term Outcomes of Custom-made Aortic Devices
Not yet recruiting NCT05554055 - Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery)
Unknown status NCT00851149 - Pro-inflammatory Cytokines in Blood From Orthopedic Surgery Compared to Abdominal Aneurysm Repair N/A
Recruiting NCT03824626 - Biomechanical Reappraisal of Planning for Thoracic Endovascular Aortic Repair
Completed NCT02867501 - Venous Distension in Patients With Aneurysmatic Arterial Disease N/A
Completed NCT03617601 - Metabolic Equivalent of Task (MET) in the Preoperative Assessment in Aortic Surgery
Completed NCT01775046 - Valiant Thoracic Stent Graft With the Captivia Delivery System in the Treatment of Descending Thoracic Aortic Diseases (VALIANT CAPTIVIA France)
Completed NCT01526811 - Endurantâ„¢ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (ENDURANT France)